The current price of KYMR is $128.12 — it has decreased by 5.97% since the previous close. Data as of Nov 5, 2026.
KYMR is up 4.52% over the past week, up 16.63% over the past month and up 113.93% over the past year. The price is above its 200-day moving average of $97.33.
Analysts' average 12-month price target for KYMR is $141.53, which implies 10.47% upside from the current price. Individual estimates range from $115.00 to $180.00.
Of the 24 analysts covering Kymera Therapeutics, Inc., 5 rate it a strong buy, 17 rate it a buy and 2 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Kymera Therapeutics, Inc. has a market capitalization of $10.94B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Kymera Therapeutics, Inc. posted a loss of $1.32 per share against an estimate of -$1.26, missing expectations by 4.76%. Upcoming reports are listed in the earnings calendar.
Kymera Therapeutics, Inc. reported revenue of $1.35M in its most recent quarter, which has decreased by 51.16% compared with the same quarter a year earlier. Analysts had expected $3.28M.
Kymera Therapeutics, Inc. has not paid any dividends over the past year.
Companies most comparable to Kymera Therapeutics, Inc. include Nurix Therapeutics, Inc., Monte Rosa Therapeutics, Inc., Arvinas, Inc. and C4 Therapeutics, Inc.
In the latest trading session KYMR moved between $124.22 and $138.00, a range of 10.76% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Kymera Therapeutics, Inc. shows a buy rating today and a strong buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Kymera Therapeutics, Inc. is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks KYMR has traded between $56.75 and $138.00. The current price is 7.16% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.